Article / 20 June 2016 at 15:30 GMT

Saxo Insight: Equity positions update

Head of Equity Strategy / Saxo Bank
  • Biogen added in the wake of 50% price decline from peak
  • Inditex stock's strong growth outlook warrants a long
  • Speculative long position in Nikkei on "Bremain" bias

By Peter Garnry

Last Friday we added a couple of new positions. A new long position was added in Biogen (BIIB:xnas) as we see value on the backdrop of a 50% decline from its peak. Recently the stock has been under pressure due to weak trial data from its multiple sclerosis drug. However, the drug portfolio still has potential to surprise in the second half. The position is hedged with the Nasdaq Biotechnology ETF (IBB:xnas).

Biogen weekly share price since 2012
Biogen stock
Source: Saxo Bank

A long position in Inditex (ITX:xmce), Spain’s largest retailer, was also added hedged 1:1 with the IBEX 35 Index (SPAIN35.I). The fast-growing retailer released strong earnings last week showing robust 15% revenue growth and its expansion into international markets and e-commerce are underpinning growth. The stock is undervalued given its growth trajectory.

We also added a speculative long position in Nikkei 225 Index (JP225.I) as we're positioning the portfolio slightly for a “UK Remain” scenario on Thursday. If we are right about “UK Remain” then we expect the JPY to sell off, leading to a short-term rally in Japanese equities.
As of this writing our equity portfolio is running at 4% net exposure, basically USD neutral, ahead of Thursday’s UK referendum. Our gross exposure is 101%

Equity positions
The full table with data on our equity positions can be found in the attached PDF.

– Edited by Clare MacCarthy


Peter Garnry is head of equity strategy at Saxo Bank

Download document

SaxoStrats - Equity Positions

20 June
staseramibutto staseramibutto
you mentioned you were long Gilead few months ago, but I don't see it anymore.
when did you decide selling it?
why should it not be a long?
21 June
SierraPt. SierraPt.
I missed your trade idea on Qihoo - when did you publish it and where?
04 July
Teofilo Teofilo
It's time is now... Get a loan in Samsung, Unicredito, Arcelor Mittal and Berkshire.
In 5 years portfolio up 50pct and GBP 20pct lower. Happy days...


The Saxo Bank Group entities each provide execution-only service and access to permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on or as a result of the use of the Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. When trading through your contracting Saxo Bank Group entity will be the counterparty to any trading entered into by you. does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of ourtrading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws. Please read our disclaimers:
- Notification on Non-Independent Invetment Research
- Full disclaimer

Check your inbox for a mail from us to fully activate your profile. No mail? Have us re-send your verification mail